Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-04-26

Clinical Trial Update: Strategy to Adapt Botulinum Toxin Doses in Dystonia

View source ↗

Summary

This clinical trial update discusses strategies for adapting botulinum toxin dosing in dystonia. It outlines study design considerations and approaches to optim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Dystonia | Status: UNKNOWN